These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34535676)

  • 1. Argininosuccinate lyase is a metabolic vulnerability in breast development and cancer.
    Karvelsson ST; Wang Q; Hilmarsdottir B; Sigurdsson A; Moestue SA; Mælandsmo GM; Halldorsson S; Gudmundsson S; Rolfsson O
    NPJ Syst Biol Appl; 2021 Sep; 7(1):36. PubMed ID: 34535676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamine-Fructose-6-Phosphate Transaminase 2 (GFPT2) Is Upregulated in Breast Epithelial-Mesenchymal Transition and Responds to Oxidative Stress.
    Wang Q; Karvelsson ST; Kotronoulas A; Gudjonsson T; Halldorsson S; Rolfsson O
    Mol Cell Proteomics; 2022 Feb; 21(2):100185. PubMed ID: 34923141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGFR Signal-Network Reconstruction Demonstrates Metabolic Crosstalk in EMT.
    Choudhary KS; Rohatgi N; Halldorsson S; Briem E; Gudjonsson T; Gudmundsson S; Rolfsson O
    PLoS Comput Biol; 2016 Jun; 12(6):e1004924. PubMed ID: 27253373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of the D492 Cell Lines to Explore Breast Morphogenesis, EMT and Cancer Progression in 3D Culture.
    Briem E; Ingthorsson S; Traustadottir GA; Hilmarsdottir B; Gudjonsson T
    J Mammary Gland Biol Neoplasia; 2019 Jun; 24(2):139-147. PubMed ID: 30684066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic re-wiring of isogenic breast epithelial cell lines following epithelial to mesenchymal transition.
    Halldorsson S; Rohatgi N; Magnusdottir M; Choudhary KS; Gudjonsson T; Knutsen E; Barkovskaya A; Hilmarsdottir B; Perander M; Mælandsmo GM; Gudmundsson S; Rolfsson Ó
    Cancer Lett; 2017 Jun; 396():117-129. PubMed ID: 28323032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
    Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
    Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Argininosuccinate lyase is a potential therapeutic target in breast cancer.
    Huang HL; Chen WC; Hsu HP; Cho CY; Hung YH; Wang CY; Lai MD
    Oncol Rep; 2015 Dec; 34(6):3131-9. PubMed ID: 26397737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Advances in the development of constraint-based genome-scale metabolic network models].
    Zhou J; Liu P; Xia J; Zhuang Y
    Sheng Wu Gong Cheng Xue Bao; 2021 May; 37(5):1526-1540. PubMed ID: 34085441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic Analysis of Epithelial to Mesenchymal Transition (EMT) Reveals Cross-talk between SNAIL and HDAC1 Proteins in Breast Cancer Cells.
    Palma Cde S; Grassi ML; Thomé CH; Ferreira GA; Albuquerque D; Pinto MT; Ferreira Melo FU; Kashima S; Covas DT; Pitteri SJ; Faça VM
    Mol Cell Proteomics; 2016 Mar; 15(3):906-17. PubMed ID: 26764010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrin alpha-2 and beta-1 expression increases through multiple generations of the EDW01 patient-derived xenograft model of breast cancer-insight into their role in epithelial mesenchymal transition in vivo gained from an in vitro model system.
    Wafai R; Williams ED; de Souza E; Simpson PT; McCart Reed AE; Kutasovic JR; Waltham M; Snell CE; Blick T; Thompson EW; Hugo HJ
    Breast Cancer Res; 2020 Dec; 22(1):136. PubMed ID: 33276802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studying the Metabolism of Epithelial-Mesenchymal Plasticity Using the Seahorse XFe96 Extracellular Flux Analyzer.
    Bhatia S; Thompson EW; Gunter JH
    Methods Mol Biol; 2021; 2179():327-340. PubMed ID: 32939731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HER2 induced EMT and tumorigenicity in breast epithelial progenitor cells is inhibited by coexpression of EGFR.
    Ingthorsson S; Andersen K; Hilmarsdottir B; Maelandsmo GM; Magnusson MK; Gudjonsson T
    Oncogene; 2016 Aug; 35(32):4244-55. PubMed ID: 26686087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WNT5A signaling impairs breast cancer cell migration and invasion via mechanisms independent of the epithelial-mesenchymal transition.
    Prasad CP; Chaurasiya SK; Guilmain W; Andersson T
    J Exp Clin Cancer Res; 2016 Sep; 35(1):144. PubMed ID: 27623766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial-mesenchymal transition induces similar metabolic alterations in two independent breast cancer cell lines.
    Kondaveeti Y; Guttilla Reed IK; White BA
    Cancer Lett; 2015 Aug; 364(1):44-58. PubMed ID: 25917568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manganese Superoxide Dismutase Expression Regulates the Switch Between an Epithelial and a Mesenchymal-Like Phenotype in Breast Carcinoma.
    Loo SY; Hirpara JL; Pandey V; Tan TZ; Yap CT; Lobie PE; Thiery JP; Goh BC; Pervaiz S; Clément MV; Kumar AP
    Antioxid Redox Signal; 2016 Aug; 25(6):283-99. PubMed ID: 27400860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic analysis of tumor necrosis factor-alpha resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype.
    Zhou C; Nitschke AM; Xiong W; Zhang Q; Tang Y; Bloch M; Elliott S; Zhu Y; Bazzone L; Yu D; Weldon CB; Schiff R; McLachlan JA; Beckman BS; Wiese TE; Nephew KP; Shan B; Burow ME; Wang G
    Breast Cancer Res; 2008; 10(6):R105. PubMed ID: 19087274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRD7 suppresses invasion and metastasis in breast cancer by negatively regulating YB1-induced epithelial-mesenchymal transition.
    Niu W; Luo Y; Zhou Y; Li M; Wu C; Duan Y; Wang H; Fan S; Li Z; Xiong W; Li X; Li G; Ren C; Li H; Zhou M
    J Exp Clin Cancer Res; 2020 Feb; 39(1):30. PubMed ID: 32028981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic analysis of ovarian cancer cells during epithelial-mesenchymal transition (EMT) induced by epidermal growth factor (EGF) reveals mechanisms of cell cycle control.
    Grassi ML; Palma CS; Thomé CH; Lanfredi GP; Poersch A; Faça VM
    J Proteomics; 2017 Jan; 151():2-11. PubMed ID: 27394697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct repression of MYB by ZEB1 suppresses proliferation and epithelial gene expression during epithelial-to-mesenchymal transition of breast cancer cells.
    Hugo HJ; Pereira L; Suryadinata R; Drabsch Y; Gonda TJ; Gunasinghe NP; Pinto C; Soo ET; van Denderen BJ; Hill P; Ramsay RG; Sarcevic B; Newgreen DF; Thompson EW
    Breast Cancer Res; 2013 Nov; 15(6):R113. PubMed ID: 24283570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of SDF-1/CXCR4-induced epithelial-mesenchymal transition by kisspeptin-10.
    Gründker C; Bauerschmitz G; Knapp J; Schmidt E; Olbrich T; Emons G
    Breast Cancer Res Treat; 2015 Jul; 152(1):41-50. PubMed ID: 26062751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.